| |
| |
|
| Insider
Information: |
Levin Alan G |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
694,614 |
|
|
Indirect Shares
|
19,963 |
|
|
| Direct
Value |
$9,764,907 |
|
|
|
Indirect Value
|
$559,164 |
|
|
| Total
Shares |
714,577 |
|
|
| Total
Value |
$10,324,071 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pfizer Inc |
PFE |
Senior Vice President |
2007-05-08 |
340,061 |
2007-05-08 |
19,963 |
Premium* |
|
|
Endo Health Solutions Inc |
ENDP |
EVP, Chief Financial O... |
2013-06-01 |
69,431 |
|
0 |
Premium* |
|
|
Cervomed Ord Shs |
CRVO |
Director |
2016-01-08 |
248,032 |
2016-01-08 |
0 |
Premium* |
|
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2023-06-13 |
37,090 |
2021-08-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PFE |
Pfizer Inc |
Senior Vice PresidentOfficer |
• – – |
2005-03-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
302,434 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice PresidentOfficer |
• – – |
2005-03-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
16,173 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice PresidentOfficer |
• – – |
2005-03-03 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
314,674 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice PresidentOfficer |
• – – |
2005-03-03 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
314,659 |
|
- |
|
| ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial OfficerOf |
• – – |
2009-06-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
43,500 |
|
- |
|
| PFE |
Pfizer Inc |
officerTitle |
• – – |
2005-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,334 |
305,453 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2006-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
71,790 |
383,819 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2006-08-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
365,829 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2006-12-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
433 |
371,188 |
0 |
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2007-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
62,140 |
435,164 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
• – – |
2010-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,875 |
10,875 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
• – – |
2011-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,368 |
16,368 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
• – – |
2012-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
16,677 |
28,953 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
• – – |
2012-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
16,677 |
33,045 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
• – – |
2012-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,023 |
50,154 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
• – – |
2013-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
7,342 |
7,342 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
• – – |
2013-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
14,683 |
47,728 |
0 |
- |
|
| CRVO |
Cervomed Ord Shs |
Director |
• • – |
2016-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
248,032 |
248,032 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
16,745 |
37,090 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2023-05-31 |
4 |
A |
$8.27 |
$11,247 |
D/D |
1,360 |
20,345 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2023-02-28 |
4 |
A |
$8.85 |
$11,248 |
D/D |
1,271 |
18,985 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2022-05-31 |
4 |
A |
$9.31 |
$10,595 |
D/D |
1,138 |
3,197 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-11-30 |
4 |
A |
$12.06 |
$9,998 |
D/D |
829 |
1,457 |
0 |
- |
|
| PFE |
Pfizer Inc |
officerTitle |
• – – |
2005-12-16 |
4 |
OE |
$12.42 |
$58,796 |
D/D |
4,734 |
310,187 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2006-08-16 |
4 |
OE |
$12.42 |
$443,618 |
D/D |
35,718 |
401,547 |
|
- |
|
49 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
